HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Family-centered empowerment approach to optimize phosphate management among hemodialysis patients: an experimental study.

AbstractBACKGROUND:
This study aimed to investigate the effect of a family-centered empowerment program on hyperphosphatemia management.
METHOD:
This experimental study was performed on 80 randomly selected eligible patients with hyperphosphatemia undergoing hemodialysis. Patients were assigned randomly to two groups of family-centered empowerment program (FCEPG) and control group (CG) by coin toss (40 people per group). Data collection tools were the researcher-made Phosphate Control Knowledge Scale, the researcher-made Adherence to Dietary Restriction of Phosphorus Intake Scale, the eight-item Morisky Medication Adherence Scale, and serum phosphorus measurements. Data were collected before the intervention, one month, and three months after the intervention. Patients in FCEPG participated in a family-centered empowerment program. The statistical significance level was considered to be 0.05.
RESULTS:
Inter-group comparisons showed no significant difference between FCEPG and CG in terms of the mean score of knowledge of phosphate control, adherence to dietary restriction of phosphorus intake, adherence to medication, and the mean serum phosphorus level before the empowerment program, but showed significant differences between them in these respects at one month after the program and three months after the program (p < 0.05). Intra-group comparisons showed a significant difference in FCEPG between the mean and standard deviation of all four variables before the empowerment program and the corresponding values one month and three months after the program (P < 0.05).
CONCLUSION:
The findings of this study can be used in various fields of healthcare in the hospital and community.
AuthorsParvaneh Vasli, Meimanat Hosseini, Malihe Nasiri, Noushin Bakhtiari
JournalBMC nephrology (BMC Nephrol) Vol. 24 Issue 1 Pg. 259 (09 03 2023) ISSN: 1471-2369 [Electronic] England
PMID37661281 (Publication Type: Randomized Controlled Trial, Journal Article)
Copyright© 2023. BioMed Central Ltd., part of Springer Nature.
Chemical References
  • Phosphates
  • Phosphorus, Dietary
  • Phosphorus
Topics
  • Humans
  • Phosphates
  • Hyperphosphatemia (drug therapy, etiology, prevention & control)
  • Phosphorus, Dietary
  • Renal Dialysis
  • Phosphorus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: